ReviewCurrent hematologic malignancy reports2021

Immunotherapies Old and New: Hematopoietic Stem Cell Transplant, Chimeric Antigen Receptor T Cells, and Bispecific Antibodies for the Treatment of Relapsed/Refractory Diffuse Large B Cell Lymphoma.

Anupama Doraiswamy et al.PubMed ↗Publisher ↗

No numbers read from the abstract.